Meanwhile, siIDO1 silencing of the IDO1 metabolic pathway alleviated immune brakes associated with immunonegative cells, such as Tregs and M2‐TAMs, which further reinforces anti‐tumor immunity. Here, IDO1 is linked to neoplasm.